Zenith Drugs Limited (NSE:ZENITHDRUG)
India · Delayed Price · Currency is INR 42.15
+0.10 (0.24%)
Oct 7, 2026, 1:08 PM IST
Zenith Drugs Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 723 | 604 | 1,230 | 1,075 | - | - | |
Market Cap Growth | -34.14% | -50.91% | 14.35% | - | - | - |
Enterprise Value | 1,271 | 1,118 | 1,389 | 1,332 | - | - |
Last Close Price | 42.15 | 35.20 | 71.70 | 62.48 | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 18.33 | 15.31 | 17.17 | 11.27 | - | - |
PS Ratio | 0.42 | 0.35 | 0.92 | 0.82 | - | - |
PB Ratio | 0.99 | 0.82 | 1.77 | 1.73 | - | - |
P/TBV Ratio | 1.05 | 0.87 | 1.78 | 1.73 | - | - |
P/OCF Ratio | 8.15 | 6.81 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 0.74 | 0.65 | 1.04 | 1.01 | - | - |
EV/EBITDA Ratio | 8.10 | 7.12 | 9.79 | 7.38 | - | - |
EV/EBIT Ratio | 13.13 | 11.54 | 12.38 | 7.96 | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.75 | 0.75 | 0.70 | 0.39 | 1.47 | 1.55 |
Debt / EBITDA Ratio | 3.51 | 3.51 | 3.43 | 1.33 | 2.64 | 2.75 |
Net Debt / Equity Ratio | 0.75 | 0.75 | 0.70 | 0.24 | 1.46 | 1.31 |
Net Debt / EBITDA Ratio | 3.50 | 3.50 | 3.41 | 0.84 | 2.61 | 2.31 |
Net Debt / FCF Ratio | -65.24 | -65.24 | -1.28 | -0.72 | -2.50 | -177.62 |
Asset Turnover | 0.98 | 0.98 | 0.90 | 1.13 | 1.38 | 1.59 |
Inventory Turnover | 2.99 | 2.99 | 2.68 | 3.47 | 4.38 | 7.67 |
Quick Ratio | 0.78 | 0.78 | 0.77 | 1.19 | 0.69 | 0.75 |
Current Ratio | 1.37 | 1.37 | 1.42 | 1.76 | 1.17 | 1.15 |
Return on Equity (ROE) | 5.53% | 5.53% | 10.88% | 23.86% | 32.71% | 29.71% |
Return on Assets (ROA) | 3.47% | 3.47% | 4.74% | 9.01% | 6.46% | 5.98% |
Return on Invested Capital (ROIC) | 5.53% | 5.76% | 8.89% | 19.85% | 17.64% | 15.48% |
Return on Capital Employed (ROCE) | 10.40% | 10.40% | 13.60% | 23.90% | 32.70% | 25.00% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 6, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 5.45% | 6.53% | 5.82% | 8.87% | - | - |
FCF Yield | -1.16% | -1.39% | -30.56% | -19.69% | - | - |
Dividend Yield | - | - | - | 0.80% | - | - |
Buyback Yield / Dilution | - | - | - | -42.91% | - | - |
Total Shareholder Return | - | - | - | -42.11% | - | - |